Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myeloid Leukemia, Childhood
Welcome,
Profile
Billing
Logout
44 Companies
74 Products
74 Products
52 Mechanisms of Action
4 Trials
352 News
«
1
2
3
4
5
6
7
8
||||||||||
AT9283
/
Otsuka
New P1/2 trial:
CRUK-CR0708-12: AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
(clinicaltrials.gov) - Sep 7, 2011
P1/2
, N=15, Recruiting,
Sponsor: Cancer Research UK
||||||||||
New P2 trial, Post-transplantation:
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
(clinicaltrials.gov) - Aug 31, 2011
P2
, N=42, Active, not recruiting,
Sponsor: Fred Hutchinson Cancer Research Center
||
||||||||
Mylotarg
(gemtuzumab ozogamicin) /
UCB, PDL, Pfizer
Biomarker, Enrollment closed:
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
(clinicaltrials.gov) - Aug 7, 2011
P=N/A
, N=1000, Active, not recruiting,
Sponsor: Children's Oncology Group
Not yet recruiting --> Active, not recruiting